 | • レポートコード：GIR-105X02390 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ベラプロストのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ベラプロストの種類別市場規模（20 Ugタブレット、40 Ugタブレット）、用途別市場規模（高血圧、脊柱管、慢性腎不全、糸球体線維症、末梢血管疾患、慢性動脈閉塞性疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ベラプロストの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Toray、Kaken Pharma、Astellas Pharma、Jeil Pharmaceutical、Beijing Tide Pharmaceutical （Charoen Pokphand Group) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：20 Ugタブレット、40 Ugタブレット ・用途別分析2016年-2026年：高血圧、脊柱管、慢性腎不全、糸球体線維症、末梢血管疾患、慢性動脈閉塞性疾患、その他 ・ベラプロストの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ベラプロストのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ベラプロストのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ベラプロストの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ベラプロストの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Beraprost market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Beraprost size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Beraprost market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Beraprost market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
20 Ug Tablet
40 Ug Tablet
Market segment by Application can be divided into
High Blood Pressure
Spinal Canal
Chronic Renal Failure
Glomerular Fibrosis
Peripheral Vascular Disease
Chronic Arterial Occlusive Disease
Other
The key market players for global Beraprost market are listed below:
Toray
Kaken Pharma
Astellas Pharma
Jeil Pharmaceutical
Beijing Tide Pharmaceutical （Charoen Pokphand Group)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Beraprost product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Beraprost, with price, sales, revenue and global market share of Beraprost in 2018 and 2019.
Chapter 3, the Beraprost competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beraprost breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Beraprost market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Beraprost sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Beraprost Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Beraprost Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 20 Ug Tablet
1.2.3 40 Ug Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Beraprost Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 High Blood Pressure
1.3.3 Spinal Canal
1.3.4 Chronic Renal Failure
1.3.5 Glomerular Fibrosis
1.3.6 Peripheral Vascular Disease
1.3.7 Chronic Arterial Occlusive Disease
1.3.8 Other
1.4 Global Beraprost Market Size & Forecast
1.4.1 Global Beraprost Sales in Value (2016-2026))
1.4.2 Global Beraprost Sales in Volume (2016-2026)
1.4.3 Global Beraprost Price by Type (2016-2026) & (US$/Pcs)
1.5 Global Beraprost Production Capacity Analysis
1.5.1 Global Beraprost Total Production Capacity (2016-2026)
1.5.2 Global Beraprost Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Beraprost Market Drivers
1.6.2 Beraprost Market Restraints
1.6.3 Beraprost Trends Analysis
2 Manufacturers Profiles
2.1 Toray
2.1.1 Toray Details
2.1.2 Toray Major Business
2.1.3 Toray Beraprost Product and Services
2.1.4 Toray Beraprost Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Kaken Pharma
2.2.1 Kaken Pharma Details
2.2.2 Kaken Pharma Major Business
2.2.3 Kaken Pharma Beraprost Product and Services
2.2.4 Kaken Pharma Beraprost Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business
2.3.3 Astellas Pharma Beraprost Product and Services
2.3.4 Astellas Pharma Beraprost Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Jeil Pharmaceutical
2.4.1 Jeil Pharmaceutical Details
2.4.2 Jeil Pharmaceutical Major Business
2.4.3 Jeil Pharmaceutical Beraprost Product and Services
2.4.4 Jeil Pharmaceutical Beraprost Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Beijing Tide Pharmaceutical （Charoen Pokphand Group)
2.5.1 Beijing Tide Pharmaceutical （Charoen Pokphand Group) Details
2.5.2 Beijing Tide Pharmaceutical （Charoen Pokphand Group) Major Business
2.5.3 Beijing Tide Pharmaceutical （Charoen Pokphand Group) Beraprost Product and Services
2.5.4 Beijing Tide Pharmaceutical （Charoen Pokphand Group) Beraprost Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Beraprost Sales by Manufacturer
3.1 Global Beraprost Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Beraprost Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Beraprost
3.4 Market Concentration Rate
3.4.1 Top 3 Beraprost Manufacturer Market Share
3.4.2 Top 6 Beraprost Manufacturer Market Share
3.5 Global Beraprost Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Beraprost Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Beraprost Market Size by Region
4.1.1 Global Beraprost Sales in Volume by Region (2016-2026)
4.1.2 Global Beraprost Revenue by Region (2016-2026)
4.2 North America Beraprost Revenue (2016-2026)
4.3 Europe Beraprost Revenue (2016-2026)
4.4 Asia-Pacific Beraprost Revenue (2016-2026)
4.5 South America Beraprost Revenue (2016-2026)
4.6 Middle East and Africa Beraprost Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Beraprost Sales in Volume by Type (2016-2026)
5.2 Global Beraprost Revenue by Type (2016-2026)
5.3 Global Beraprost Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Beraprost Sales in Volume by Application (2016-2026)
6.2 Global Beraprost Revenue by Application (2016-2026)
6.3 Global Beraprost Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Beraprost Sales by Type (2016-2026)
7.2 North America Beraprost Sales by Application (2016-2026)
7.3 North America Beraprost Market Size by Country
7.3.1 North America Beraprost Sales in Volume by Country (2016-2026)
7.3.2 North America Beraprost Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Beraprost Sales by Type (2016-2026)
8.2 Europe Beraprost Sales by Application (2016-2026)
8.3 Europe Beraprost Market Size by Country
8.3.1 Europe Beraprost Sales in Volume by Country (2016-2026)
8.3.2 Europe Beraprost Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Beraprost Sales by Type (2016-2026)
9.2 Asia-Pacific Beraprost Sales by Application (2016-2026)
9.3 Asia-Pacific Beraprost Market Size by Region
9.3.1 Asia-Pacific Beraprost Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Beraprost Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Beraprost Sales by Type (2016-2026)
10.2 South America Beraprost Sales by Application (2016-2026)
10.3 South America Beraprost Market Size by Country
10.3.1 South America Beraprost Sales in Volume by Country (2016-2026)
10.3.2 South America Beraprost Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Beraprost Sales by Type (2016-2026)
11.2 Middle East & Africa Beraprost Sales by Application (2016-2026)
11.3 Middle East & Africa Beraprost Market Size by Country
11.3.1 Middle East & Africa Beraprost Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Beraprost Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Beraprost Typical Distributors
12.3 Beraprost Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Beraprost Revenue by Type, (USD Million), 2021-2026
Table 2. Global Beraprost Revenue by Application, (USD Million), 2021-2026
Table 3. Toray Basic Information, Manufacturing Base and Competitors
Table 4. Toray Major Business
Table 5. Toray Beraprost Product and Services
Table 6. Toray Beraprost Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Kaken Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Kaken Pharma Major Business
Table 9. Kaken Pharma Beraprost Product and Services
Table 10. Kaken Pharma Beraprost Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Astellas Pharma Major Business
Table 13. Astellas Pharma Beraprost Product and Services
Table 14. Astellas Pharma Beraprost Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Jeil Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Jeil Pharmaceutical Major Business
Table 17. Jeil Pharmaceutical Beraprost Product and Services
Table 18. Jeil Pharmaceutical Beraprost Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Beijing Tide Pharmaceutical （Charoen Pokphand Group) Basic Information, Manufacturing Base and Competitors
Table 20. Beijing Tide Pharmaceutical （Charoen Pokphand Group) Major Business
Table 21. Beijing Tide Pharmaceutical （Charoen Pokphand Group) Beraprost Product and Services
Table 22. Beijing Tide Pharmaceutical （Charoen Pokphand Group) Beraprost Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Beraprost Sales by Manufacturer (2019-2021e) & (M Pcs)
Table 24. Global Beraprost Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Beraprost, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Beraprost Production Capacity by Company, (M Pcs): 2020 VS 2021
Table 27. Head Office and Beraprost Production Site of Key Manufacturer
Table 28. Beraprost New Entrant and Capacity Expansion Plans
Table 29. Beraprost Mergers & Acquisitions in the Past Five Years
Table 30. Global Beraprost Sales by Region (2016-2021e) & (M Pcs)
Table 31. Global Beraprost Sales by Region (2021-2026) & (M Pcs)
Table 32. Global Beraprost Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Beraprost Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Beraprost Sales by Type (2016-2021e) & (M Pcs)
Table 35. Global Beraprost Sales by Type (2021-2026) & (M Pcs)
Table 36. Global Beraprost Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Beraprost Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Beraprost Price by Type (2016-2021e) & (US$/Pcs)
Table 39. Global Beraprost Price by Type (2021-2026) & (US$/Pcs)
Table 40. Global Beraprost Sales by Application (2016-2021e) & (M Pcs)
Table 41. Global Beraprost Sales by Application (2021-2026) & (M Pcs)
Table 42. Global Beraprost Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Beraprost Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Beraprost Price by Application (2016-2021e) & (US$/Pcs)
Table 45. Global Beraprost Price by Application (2021-2026) & (US$/Pcs)
Table 46. North America Beraprost Sales by Country (2016-2021e) & (M Pcs)
Table 47. North America Beraprost Sales by Country (2021-2026) & (M Pcs)
Table 48. North America Beraprost Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Beraprost Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Beraprost Sales by Type (2016-2021e) & (M Pcs)
Table 51. North America Beraprost Sales by Type (2021-2026) & (M Pcs)
Table 52. North America Beraprost Sales by Application (2016-2021e) & (M Pcs)
Table 53. North America Beraprost Sales by Application (2021-2026) & (M Pcs)
Table 54. Europe Beraprost Sales by Country (2016-2021e) & (M Pcs)
Table 55. Europe Beraprost Sales by Country (2021-2026) & (M Pcs)
Table 56. Europe Beraprost Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Beraprost Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Beraprost Sales by Type (2016-2021e) & (M Pcs)
Table 59. Europe Beraprost Sales by Type (2021-2026) & (M Pcs)
Table 60. Europe Beraprost Sales by Application (2016-2021e) & (M Pcs)
Table 61. Europe Beraprost Sales by Application (2021-2026) & (M Pcs)
Table 62. Asia-Pacific Beraprost Sales by Region (2016-2021e) & (M Pcs)
Table 63. Asia-Pacific Beraprost Sales by Region (2021-2026) & (M Pcs)
Table 64. Asia-Pacific Beraprost Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Beraprost Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Beraprost Sales by Type (2016-2021e) & (M Pcs)
Table 67. Asia-Pacific Beraprost Sales by Type (2021-2026) & (M Pcs)
Table 68. Asia-Pacific Beraprost Sales by Application (2016-2021e) & (M Pcs)
Table 69. Asia-Pacific Beraprost Sales by Application (2021-2026) & (M Pcs)
Table 70. South America Beraprost Sales by Country (2016-2021e) & (M Pcs)
Table 71. South America Beraprost Sales by Country (2021-2026) & (M Pcs)
Table 72. South America Beraprost Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Beraprost Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Beraprost Sales by Type (2016-2021e) & (M Pcs)
Table 75. South America Beraprost Sales by Type (2021-2026) & (M Pcs)
Table 76. South America Beraprost Sales by Application (2016-2021e) & (M Pcs)
Table 77. South America Beraprost Sales by Application (2021-2026) & (M Pcs)
Table 78. Middle East & Africa Beraprost Sales by Country (2016-2021e) & (M Pcs)
Table 79. Middle East & Africa Beraprost Sales by Country (2021-2026) & (M Pcs)
Table 80. Middle East & Africa Beraprost Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Beraprost Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Beraprost Sales by Type (2016-2021e) & (M Pcs)
Table 83. Middle East & Africa Beraprost Sales by Type (2021-2026) & (M Pcs)
Table 84. Middle East & Africa Beraprost Sales by Application (2016-2021e) & (M Pcs)
Table 85. Middle East & Africa Beraprost Sales by Application (2021-2026) & (M Pcs)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Beraprost Typical Distributors
Table 89. Beraprost Typical Customers
List of Figures
Figure 1. Beraprost Picture
Figure 2. Global Beraprost Sales Market Share by Type in 2020
Figure 3. 20 Ug Tablet
Figure 4. 40 Ug Tablet
Figure 5. Global Beraprost Sales Market Share by Application in 2020
Figure 6. High Blood Pressure
Figure 7. Spinal Canal
Figure 8. Chronic Renal Failure
Figure 9. Glomerular Fibrosis
Figure 10. Peripheral Vascular Disease
Figure 11. Chronic Arterial Occlusive Disease
Figure 12. Other
Figure 13. Global Beraprost Market Size, (USD Million) & (M Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Beraprost Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Beraprost Sales (2016-2026) & (M Pcs)
Figure 16. Global Beraprost Price by Type (2016-2026) & (US$/Pcs)
Figure 17. Global Beraprost Production Capacity (2016-2026) & (M Pcs)
Figure 18. Global Beraprost Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Beraprost Market Drivers
Figure 20. Beraprost Market Restraints
Figure 21. Beraprost Market Trends
Figure 22. Global Beraprost Sales Market Share by Manufacturer in 2020
Figure 23. Global Beraprost Revenue Market Share by Manufacturer in 2020
Figure 24. Beraprost Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Beraprost Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Beraprost Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Beraprost Sales Market Share by Region (2016-2026)
Figure 28. Global Beraprost Revenue Market Share by Region (2016-2026)
Figure 29. North America Beraprost Revenue (2016-2026) & (USD Million)
Figure 30. Europe Beraprost Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Beraprost Revenue (2016-2026) & (USD Million)
Figure 32. South America Beraprost Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Beraprost Revenue (2016-2026) & (USD Million)
Figure 34. Global Beraprost Sales Market Share by Type (2016-2026)
Figure 35. Global Beraprost Revenue Market Share by Type (2016-2026)
Figure 36. Global Beraprost Price by Type (2016-2026) & (US$/Pcs)
Figure 37. Global Beraprost Sales Market Share by Application (2016-2026)
Figure 38. Global Beraprost Revenue Market Share by Application (2016-2026)
Figure 39. Global Beraprost Price by Application (2016-2026) & (US$/Pcs)
Figure 40. North America Beraprost Sales Market Share by Type (2016-2026)
Figure 41. North America Beraprost Sales Market Share by Application (2016-2026)
Figure 42. North America Beraprost Sales Market Share by Country (2016-2026)
Figure 43. North America Beraprost Revenue Market Share by Country (2016-2026)
Figure 44. United States Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Beraprost Sales Market Share by Type (2016-2026)
Figure 48. Europe Beraprost Sales Market Share by Application (2016-2026)
Figure 49. Europe Beraprost Sales Market Share by Country (2016-2026)
Figure 50. Europe Beraprost Revenue Market Share by Country (2016-2026)
Figure 51. Germany Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Beraprost Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Beraprost Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Beraprost Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Beraprost Revenue Market Share by Region (2016-2026)
Figure 60. China Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Beraprost Sales Market Share by Type (2016-2026)
Figure 67. South America Beraprost Sales Market Share by Application (2016-2026)
Figure 68. South America Beraprost Sales Market Share by Country (2016-2026)
Figure 69. South America Beraprost Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Beraprost Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Beraprost Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Beraprost Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Beraprost Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Beraprost Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のベラプロストナトリウム市場 2021：企業別、地域別、種類・用途別 The Beraprost Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…- 塩化ベラプロストタブレットの世界市場2018-2025 In 2018, the global Beraprost Sodium Tablets market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Beraprost Sodium Tablets. T…
- ベラプロストの世界市場2018-2025 In 2018, the global Beraprost market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Beraprost. This study researches the marke…
- 慢性閉塞性肺疾患の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 慢性閉塞性肺動脈の病気トリートメントの世界市場2018-2025 In 2018, the global Chronic Obstructive Pulmonary Disease Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Chro…